Literature DB >> 27742461

Association of pellicle growth morphological characteristics and clinical presentation of Mycobacterium tuberculosis isolates.

Ranjana Arora1, Lisa Armitige2, Audrey Wanger3, Robert L Hunter3, Shen-An Hwang4.   

Abstract

Trehalose 6,6'dimycolate (TDM) is a glycolipid found in nearly pure form on the surface of virulent Mycobacterium tuberculosis (MTB). This manuscript investigated the production of TDM, growth rate and colony morphology of multiple strains of MTB, each of which had been isolated from both pulmonary (sputum) and extrapulmonary sites of multiple patients. Since sputum contains MTB primarily from cavities and extrapulmonary biopsies are typically granulomas, this provided an opportunity to compare the behavior of single strains of MTB that had been isolated from cavities and granulomas. The results demonstrated that MTB isolated from pulmonary sites produced more TDM (3.23 ± 1.75 μg TDM/mg MTB), grew more rapidly as thin spreading pellicles, demonstrated early cording, and climbed culture well walls. In contrast, extrapulmonary isolates produced less TDM (1.42 ± 0.58 μg TDM/mg MTB) (p < 0.001) and grew as discrete patches with little tendency to spread or climb. Both Beijing pulmonary isolates and the non-Beijing pulmonary isolates produced significantly more TDM (1.64 ± 0.46 μg TDM/mg MTB) and grew faster than the Beijing and non-Beijing extrapulmonary isolates (1.14 ± 0.63 μg TDM/mg MTB) (p < 0.001 and p < 0.005 respectively). These results indicate that MTB from pulmonary sites (cavities) grows faster and produces more TDM than strains isolated from extrapulmonary sites (granulomas). This report suggests a critical role for TDM in cavitary TB.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Beijing; Mycobacterium tuberculosis; Trehalose dimycolate

Mesh:

Substances:

Year:  2016        PMID: 27742461     DOI: 10.1016/j.tube.2016.09.015

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  3 in total

1.  Evaluation of a temperature-restricted, mucosal tuberculosis vaccine in guinea pigs.

Authors:  Tuhina Gupta; Monica LaGatta; Shelly Helms; Rebecca L Pavlicek; Simon O Owino; Kaori Sakamoto; Tamas Nagy; Stephen B Harvey; Mark Papania; Stephanie Ledden; Kevin T Schultz; Candace McCombs; Frederick D Quinn; Russell K Karls
Journal:  Tuberculosis (Edinb)       Date:  2018-10-19       Impact factor: 3.131

2.  The BCGΔBCG1419c Vaccine Candidate Reduces Lung Pathology, IL-6, TNF-α, and IL-10 During Chronic TB Infection.

Authors:  Mario A Flores-Valdez; César Pedroza-Roldán; Michel de Jesús Aceves-Sánchez; Eliza J R Peterson; Nitin S Baliga; Rogelio Hernández-Pando; JoLynn Troudt; Elizabeth Creissen; Linda Izzo; Helle Bielefeldt-Ohmann; Thomas Bickett; Angelo A Izzo
Journal:  Front Microbiol       Date:  2018-06-12       Impact factor: 5.640

3.  Aggregation state of Mycobacterium tuberculosis impacts host immunity and augments pulmonary disease pathology.

Authors:  Afsal Kolloli; Ranjeet Kumar; Pooja Singh; Anshika Narang; Gilla Kaplan; Alex Sigal; Selvakumar Subbian
Journal:  Commun Biol       Date:  2021-11-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.